載入...
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
Despite advances in cytotoxic chemotherapy and targeted therapies, 5-year survival rates remain low for patients with advanced breast cancer at diagnosis. This highlights the limited effectiveness of current treatment options. An improved understanding of cellular functions associated with the devel...
Na minha lista:
| 發表在: | Onco Targets Ther |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4676614/ https://ncbi.nlm.nih.gov/pubmed/26675495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S88037 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|